Table 1.
Variables | N | % |
---|---|---|
Sex | ||
Male | 13 | 54 |
Female | 11 | 46 |
Tumour height | ||
≤ 5 cm | 11 | 46 |
6–10 cm | 8 | 33 |
11–15 cm | 5 | 21 |
cT stage | ||
0 | 1 | 4 |
1 | 1 | 4 |
2 | 8 | 33 |
3 | 12 | 50 |
4 | 2 | 8 |
cN stage | ||
0 | 15 | 63 |
1 | 3 | 13 |
2 | 6 | 25 |
cM stage | ||
0 | 14 | 58 |
1 | 9 | 38 |
X | 1 | 4 |
Management | ||
Direct surgery | 5 | 21 |
Radiotherapya | 10 | 42 |
Chemoradiotherapy | 3 | 13 |
Palliative | 4 | 17 |
Otherb | 2 | 8 |
pT stage | ||
0c | 3 | 0 |
1 | 2 | 8 |
2 | 3 | 13 |
3 | 10 | 42 |
4 | 0 | 0 |
No specimen yet/ever | 6 | 25 |
pN stage | ||
0 | 10 | 42 |
1 | 6 | 25 |
2 | 2 | 8 |
No specimen yet/ever | 6 | 25 |
Adjuvant therapy | ||
No | 5 | 25 |
Yes | 5 | 46 |
c clinical, p pathological
aOne patient with a clinical complete response, in watch-and-wait programme; one patient declined curative surgery due to intervening femur fracture
bOne patient referred for surgery of a synchronous lung metastasis from renal carcinoma; one patient underwent diagnostic transanal endoscopic microsurgery
cOne patient with dysplasia; one patient with complete pathological response; one patient with no residual tumour